about
Prognostic effect of high-flux hemodialysis in patients with chronic kidney diseaseLoss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK).Pathological aspects of lipid peroxidation.High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport.Psychological distress and depression in patients with chronic kidney disease.Depression and chronic kidney disease: A review for clinicians.The blood compatibilities of blood purification membranes and other materials developed in Japan.Di-(2-ethylhexyl) phthalate accelerates atherosclerosis in apolipoprotein E-deficient mice.Venous versus arterial iron administration in haemodialysis. Influence on erythrocytes antioxidant parameters.Biochemical oxidative stress-related markers in patients with obstructive sleep apnea.Circulating plasma antioxidants, inflammatory markers and asymptomatic carotid atherosclerosis in end-stage renal disease patients: a case control study.LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.Ankyrin is the major oxidised protein in erythrocyte membranes from end-stage renal disease patients on chronic haemodialysis and oxidation is decreased by dialysis and vitamin C supplementation.Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.The relationship between glutathione peroxidase and bioimpedance parameters in nondiabetic hemodialysis patients.
P2860
Q26775524-3271CE8A-1688-4A84-9BDF-4457624F4C3CQ30414767-FD5C2193-89A9-4391-AB97-F680D31513D9Q34137628-B5A2F0C0-7608-44B4-8592-1FF93C19F297Q37620430-5F8C2F6D-046F-45BE-98EC-366E39914E05Q38027185-E3E77C6A-1EFF-48EB-BEF0-DEAD6BD443D5Q38198493-CBC3A5C3-0724-4C2C-B4E8-CB0117F8DCCDQ38586090-44110608-8DC7-4883-A37D-EB29D4CA1A71Q38951768-D418E886-8011-4CF0-9AD7-8FF22A67A376Q41818532-F64F8661-B56A-4FDA-AB14-3A624C34336CQ43103931-982C1A75-8B71-41F6-9AAA-88C463C3A9BDQ43105925-1376C016-F5C6-4AF0-B8F8-E27F4503479DQ47661129-44DEDC84-2E0F-4F12-99E9-E1E93562CCAEQ50456717-0B1D4342-9B4D-435F-8CBE-A20068B4FA6EQ50522179-1F908215-F6CD-4EAA-B24D-6029FA573372Q53204616-5A3EE1C0-03AC-409B-9481-CC8D54266265
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oxidative stress in hemodialysis.
@en
Oxidative stress in hemodialysis.
@nl
type
label
Oxidative stress in hemodialysis.
@en
Oxidative stress in hemodialysis.
@nl
prefLabel
Oxidative stress in hemodialysis.
@en
Oxidative stress in hemodialysis.
@nl
P356
P1476
Oxidative stress in hemodialysis.
@en
P2093
Jonathan Himmelfarb
P304
P356
10.1159/000130658
P577
2008-01-01T00:00:00Z